BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33670444)

  • 1. First Evidence for a Role of Siglec-8 in Breast Cancer.
    Trebo A; Ditsch N; Degenhardt T; Kuhn C; Rahmeh M; Schmoeckel E; Mayr D; Czogalla B; Kolben T; Meister S; Mahner S; Jeschke U; Hester A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.
    Tanida S; Akita K; Ishida A; Mori Y; Toda M; Inoue M; Ohta M; Yashiro M; Sawada T; Hirakawa K; Nakada H
    J Biol Chem; 2013 Nov; 288(44):31842-52. PubMed ID: 24045940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of Siglec-8 associates with poor prognosis in patients with gastric cancer after surgical resection.
    Cao Y; Liu H; Zhang H; Lin C; Li R; Zhang W; Shen Z; Xu J
    Tumour Biol; 2016 Aug; 37(8):10883-91. PubMed ID: 26883254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
    Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
    J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olig2 is expressed late in human eosinophil development and controls Siglec-8 expression.
    Hwang SM; Uhm TG; Lee SK; Kong SK; Jung KH; Binas B; Chai YG; Park SW; Chung IY
    J Leukoc Biol; 2016 Oct; 100(4):711-723. PubMed ID: 27154355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma.
    Ou C; Liu L; Wang J; Dai S; Qu Y; Xiong Y; Xi W; Xu J; Guo J
    Urol Oncol; 2017 Oct; 35(10):607.e1-607.e8. PubMed ID: 28619634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.
    Tomioka Y; Morimatsu M; Nishijima K; Usui T; Yamamoto S; Suyama H; Ozaki K; Ito T; Ono E
    Biochem Biophys Res Commun; 2014 Jul; 450(1):532-7. PubMed ID: 24924635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
    Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
    J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
    Tateno H; Crocker PR; Paulson JC
    Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
    Yousef GM; Ordon MH; Foussias G; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
    Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
    Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.
    Siddiqui S; Schwarz F; Springer S; Khedri Z; Yu H; Deng L; Verhagen A; Naito-Matsui Y; Jiang W; Kim D; Zhou J; Ding B; Chen X; Varki N; Varki A
    J Biol Chem; 2017 Jan; 292(3):1029-1037. PubMed ID: 27920204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.
    Beatson R; Tajadura-Ortega V; Achkova D; Picco G; Tsourouktsoglou TD; Klausing S; Hillier M; Maher J; Noll T; Crocker PR; Taylor-Papadimitriou J; Burchell JM
    Nat Immunol; 2016 Nov; 17(11):1273-1281. PubMed ID: 27595232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.
    Wei Y; Chhiba KD; Zhang F; Ye X; Wang L; Zhang L; Robida PA; Moreno-Vinasco L; Schnaar RL; Roers A; Hartmann K; Lee CM; Demers D; Zheng T; Bochner BS; Zhu Z
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MiR-215 in Hirschsprung's Disease Pathogenesis by Targeting SIGLEC-8.
    Lei H; Li H; Xie H; Du C; Xia Y; Tang W
    Cell Physiol Biochem; 2016; 40(6):1646-1655. PubMed ID: 28006787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.
    Stanczak MA; Siddiqui SS; Trefny MP; Thommen DS; Boligan KF; von Gunten S; Tzankov A; Tietze L; Lardinois D; Heinzelmann-Schwarz V; von Bergwelt-Baildon M; Zhang W; Lenz HJ; Han Y; Amos CI; Syedbasha M; Egli A; Stenner F; Speiser DE; Varki A; Zippelius A; Läubli H
    J Clin Invest; 2018 Nov; 128(11):4912-4923. PubMed ID: 30130255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
    Jones C; Virji M; Crocker PR
    Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.